Solving the Growing Incidence of Mental Health Conditions

Through clinical trials of psychedelic inspired medicines and therapies

MindMed Clinical Trials

We are researching & developing a broad range of compounds, with the goal of unlocking new pathways for patients to experience sustained mental healing.

CLINICAL TRIALS

PRE-DISCOVERY

DISCOVERY

PRE-CLINICAL

PHASE 1A

PHASE 2A

PHASE 2B

PHASE 3

MINDMED DEVELOP (Commercial Drug Development Programs)

Anxiety - Project Lucy

Anxiety - Project Lucy

PHASE 2A

18-MC

Opioid Withdrawal

Opioid Withdrawal

PHASE 2A

LSD Microdosing

Adult ADHD

Adult ADHD

PHASE 2A

MINDMED DISCOVER (R&D Collaborations)

University Hospital Basel

LSD Assisted Therapy

Cluster Headaches

Multiple Ongoing or Completed:
 on LSD, MDMA, DMT, Psilocybin

LSD Assisted Therapy

PHASE 2

Cluster Headaches

PHASE 2

Multiple Ongoing or Completed:
 on LSD, MDMA, DMT, Psilocybin

PHASE 1

Our Philosophy

Overcome

We focus on helping patients overcome rather than survive

We believe patients deserve better than to linger in symptom management forever. We help patients make breakthroughs that get them out of the symptom management cycle that’s all too commonplace in mental healthcare.

Community

We’re building a community with high standards of efficacy and compassion

Effective mental healthcare requires a coordinated effort from therapists, drug developers, and patients. We need shared data to drive insights and better treatment, so we’re working to build that community through partnerships and programs. We hold ourselves and our partners to the highest standards of efficacy and compassion so that we can progress the industry — and patient outcomes — faster.

Toolset

Next-Gen R&D

Developing best-in-class mental health care means more than clinical testing. In addition to conducting trials for the compounds we’re bringing to market, we’re also focused on next-gen research & development, comprehensive treatment programs and integrated toolsets that empower therapists to focus on what they do best.

People

We have the right people for the right reasons

Our interdisciplinary team of drug development veterans, savvy technologists, and mental health experts was purpose-built to tackle these challenges. With over a century of combined experience in product development and commercialization, we have the know-how and the heart to introduce a better approach to mental health.

Robert Barrow Portrait

Robert Barrow

Chief Executive Officer

Daniel R Karlin, MD MA Portrait

Daniel R Karlin, MD MA

Chief Medical Officer

Miri Halperin Wernli, PhD Portrait

Miri Halperin Wernli, PhD

Executive President and Board Director

Bradford Cross Portrait

Bradford Cross

Chief Technology Officer

Donald Gehlert, PhD Portrait

Donald Gehlert, PhD

Chief Scientific Officer

Dave Guebert Portrait

Dave Guebert

Chief Financial Officer

Shahera St. John Portrait

Shahera St. John

VP, Programs

Peter Mack, PhD Portrait

Peter Mack, PhD

VP, Pharmaceutical Development

Nico Forte Portrait

Nico Forte

VP, Business Operations and Development

Carole Abel Portrait

Carole Abel

VP, EU Operations & Alliances, and Program Leader LSD

Jakub Klimes Portrait

Jakub Klimes

VP, Global Operations

Carol Gaines, MD Portrait

Carol Gaines, MD

Senior Medical Director

Stephen Schneider, PhD Portrait

Stephen Schneider, PhD

Sr. Director, Drug Substance Development

Lysa Triantafillou Portrait

Lysa Triantafillou

Senior Director of Clinical Quality Assurance

Jamie Freedman Portrait

Jamie Freedman

Director of Clinical Operations

Madeline Feldman Portrait

Madeline Feldman

Director of Strategy & Operations

Julie Tripp Portrait

Julie Tripp

Director of Toxicology

Jamileh Jemison, MD Portrait

Jamileh Jemison, MD

Digital Clinical Director

Todd Solomon, PhD Portrait

Todd Solomon, PhD

Digital Clinical Director

Martin Majernik Portrait

Martin Majernik

Director of Digital Product Lifecycle

Gennady Smagin Portrait

Gennady Smagin

Director of Pharmacology

Amber Doty Portrait

Amber Doty

Director of Pharmaceutical Development

Dustin Melton Portrait

Dustin Melton

Director of Pharmaceutical Development

Stanley D Glick, MD PhD Portrait

Stanley D Glick, MD PhD

Scientific Advisor

Natalie Wheeler, PhD Portrait

Natalie Wheeler, PhD

Medical Science Liaison with Dova Pharmaceuticals

Maurizio Fava, MD Portrait

Maurizio Fava, MD

Member, Scientific Advisory Board Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)

Peter Bergethon, MD Portrait

Peter Bergethon, MD

Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.

Robert Malenka, MD PhD Portrait

Robert Malenka, MD PhD

Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University

Kenneth Alper, MD Portrait

Kenneth Alper, MD

Clinical Associate Professor of Psychiatry and Neurology at the New York University School of Medicine

Sarah McCallum, PhD Portrait

Sarah McCallum, PhD

Associate Professor of Neuroscience and Experimental Therapeutics (DNET) at Albany Medical College

John Rotrosen, MD Portrait

John Rotrosen, MD

Professor of Psychiatry with New York University’s Langone’s Department of Psychiatry

Robert Dworkin, PhD Portrait

Robert Dworkin, PhD

Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester

Bryan L. Roth, MD, PhD Portrait

Bryan L. Roth, MD, PhD

Professor of Pharmacology, University of North Carolina School of Medicine; Director of the National Institute of Mental Health Psychoactive Drug Screening Program

Matthew W Johnson, PhD Portrait

Matthew W Johnson, PhD

Clinical Advisor

Peter Gasser, MD Portrait

Peter Gasser, MD

Clinical Advisor

Matthias Liechti, MD PhD Portrait

Matthias Liechti, MD PhD

Scientific Collaborator & Advisor

Kim PC Kuypers, PhD Portrait

Kim PC Kuypers, PhD

Scientific Collaborator & Advisor

Sarah Y Vinson, MD Portrait

Sarah Y Vinson, MD

Board Director, Member of Audit Committee

Brigid Makes Portrait

Brigid Makes

Board Director, Chair of Audit Committee, Member of Compensation, Nomination and Governance Committee

Perry Dellelce Portrait

Perry Dellelce

Chairman, Member of Nomination and Governance Committees

Stephen L. Hurst, JD Portrait

Stephen L. Hurst, JD

Co-Founder and Board Director

Andreas Krebs Portrait

Andreas Krebs

Board Director

Carol Vallone Portrait

Carol Vallone

Board Director

JR Rahn Portrait

JR Rahn

Co-Founder

Scott Freeman, MD Portrait

Scott Freeman, MD

Co-Founder & Clinical Advisor

Leonard Latchman Portrait

Leonard Latchman

Co-Founder

Craig Conant Portrait

Craig Conant

Associate Director, Clinical Operations

Sarah Karas Portrait

Sarah Karas

Associate Director, Clinical Science

Rachel Chasse Portrait

Rachel Chasse

Sr Clinical Programs Manager

Matus Hajduk Portrait

Matus Hajduk

Sr Clinical Operations Manager

Alex Deschamps Portrait

Alex Deschamps

Clinical Research Coordinator

Shenique Gardner Portrait

Shenique Gardner

Clinical Research Coordinator

Cordia Simmons Portrait

Cordia Simmons

Clinical Trial Assistant

Jon Polaha Portrait

Jon Polaha

Financial Analyst

Klara Kleinova Portrait

Klara Kleinova

People & Business Ops Specialist

Georgios Lampadariou Portrait

Georgios Lampadariou

Senior Product Manager

Dana Rajtarova Portrait

Dana Rajtarova

Senior Business Development Manager

Ondrej Skala Portrait

Ondrej Skala

Associate Project Manager

Tomas Stefanicka Portrait

Tomas Stefanicka

Infrastructure Lead

Peter Dubec Portrait

Peter Dubec

Product Engineering Lead

Alexander Wald Portrait

Alexander Wald

iOS Engineer

Adam Kolar Portrait

Adam Kolar

Machine Learning Lead

Miguel Amável Pinheiro, PhD Portrait

Miguel Amável Pinheiro, PhD

Machine Learning Lead

Martin Pilch Portrait

Martin Pilch

Senior iOS Engineer

Branislav Rariga Portrait

Branislav Rariga

Senior Designer

Ezekiel Powdar Portrait

Ezekiel Powdar

Clinical Research Coordinator

Michal Lietava Portrait

Michal Lietava

Sr Finance Manager

Enriko Malinak Portrait

Enriko Malinak

Sr Legal Specialist

Alena Vankova Portrait

Alena Vankova

Talent & People Ops Specialist

Daniel Gavin Portrait

Daniel Gavin

Senior Recruiter

Maria Estrada Portrait

Maria Estrada

Executive Assistant to CEO

Wenna Wu Portrait

Wenna Wu

People & Business Ops Generalist

Michal Trebula Portrait

Michal Trebula

Finance Specialist

Libby McLean Portrait

Libby McLean

Junior Research & Operations Specialist

Here to Stay

We’re built for operational agility and a long-run business model

This is a rapidly evolving space; we’re committed to building a business that becomes a long-lasting institution in effective mental health treatment — not a flash-in-the-pan startup that’s here today and gone tomorrow.

Patients-first

We’re a new kind of pharma company

We believe that, as a society, we’re at the start of a paradigm shift in mental health. We want to lead the way in doing it right. That means we’re community-focused, honest, and transparent. Together we can improve our collective mental health.

Quotation Marks

This could save lives, cure depression, help alcoholism, get people off opioids—why wouldn’t I want to be invested?”

Kevin O'Leary headshot
Kevin O'Leary Venture Capital Investor

MindMed could have the key to providing the upsides of psychedelic drugs for both focus and addiction treatment—while cutting out the downsides of tripping.”

 headshot

MindMed named one of 36 startups that could change the world

 headshot